0 Комментарии
0 Поделились
17 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Inflammatory Bowel Disease Drugs Market: 2024 Analysis, Size, Key Players, Industry Research Trends & Forecast 2031Inflammatory Bowel Disease Drugs Market Analysis The global Inflammatory Bowel Disease (IBD) Drugs Market, valued at USD 21.15 billion in 2023, is expected to reach USD 27.65 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.47% during the forecast period from 2024 to 2031. Inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, is a chronic...0 Комментарии 0 Поделились 40 Просмотры 0 предпросмотр
- Inflammatory Bowel Disease Treatment Market Analysis, Size, Share, and Forecast 2031The Inflammatory Bowel Disease Treatment Market in 2023 is US$ 21.11 billion, and is expected to reach US$ 28.49 billion by 2031 at a CAGR of 3.82%. FutureWise Research published a report that analyzes Inflammatory Bowel Disease Treatment Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the...0 Комментарии 0 Поделились 36 Просмотры 0 предпросмотр
- Inflammatory Bowel Disease Treatment Market Trends and Market Set For Rapid Growth with Great CAGR by Forecast 2030Market Overview The Inflammatory Bowel Disease Treatment Market Insights And Analysis by Drug Class (TNF Inhibitors, Aminosalicylates) Disease Indication (Ulcerative Colitis, Crohn’s Disease) Distribution Channel (Hospital Pharmacy), End-User (Hospitals & Clinics)—Forecast till 2030 During the forecast period, the Inflammatory Bowel Disease Treatment...0 Комментарии 0 Поделились 969 Просмотры 0 предпросмотр
- Inflammatory Bowel Disease is Estimated to Witness High Growth Owing to Rising Awareness and Product LaunchesInflammatory bowel disease (IBD) refers to conditions that cause chronic inflammation to the gastrointestinal tract. The most common types of IBD are Crohn's disease and ulcerative colitis. Crohn's disease can affect any part of the gastrointestinal tract from mouth to anus, whereas ulcerative colitis affects only the large intestine and rectum. IBD drugs aim to induce and maintain remission by...0 Комментарии 0 Поделились 797 Просмотры 0 предпросмотр
- Inflammatory Bowel Disease Treatment Market to Witness Significant GrowthSWOT Analysis Strength: Inflammatory bowel disease market comprises various treatment options such as aminosalicylates, corticosteroids and immunosuppressant drugs which helps in managing the symptoms. Also, the increasing research and development activities by major manufacturers are focusing on developing novel biologics and biosimilars which is likely to drive the market growth over the...0 Комментарии 0 Поделились 752 Просмотры 0 предпросмотр
- Inflammatory Colitis Drug Market Size, Share, Key Players, Growth Trend, and Forecast, 2028Developments in biosimilars, increasing prevalence rate of Inflammatory Colitis, and changing lifestyle have resulted in boosting the Inflammatory Colitis Drug market. The global inflammatory colitis drug market is forecast to reach USD 10.69 Billion by 2028, according to a new report by Reports and Data. Inflammatory colitis (UC) can be defined as an inflammatory...0 Комментарии 0 Поделились 2245 Просмотры 0 предпросмотр
- Remicade Biosimilars Market is Estimated to Witness High Growth Owing to Increased Use for the Treatment of Rheumatoid ArthritisRemicade is a biologic disease-modifying anti-rheumatic drug used for the treatment of various autoimmune diseases. It is primarily used for rheumatoid arthritis, Crohn's disease, ulcerative colitis. Remicade biosimilars offer effective treatment alternatives at lower costs. This has increased the use of Remicade biosimilars in recent years. The global Remicade biosimilars Market is estimated...0 Комментарии 0 Поделились 785 Просмотры 0 предпросмотр